When Does TB IRIS Happen?
TB-associated Immune Reconstitution Inflammatory Syndrome (IRIS) typically occurs when antiretroviral therapy (ART) is initiated during tuberculosis treatment in HIV-coinfected patients, with highest risk when ART is started within 2 weeks of beginning TB therapy, particularly in patients with CD4+ counts <50 cells/μL 1.
Timing and Risk Factors
When IRIS Develops
- Paradoxical IRIS: Occurs after starting ART in patients already on TB treatment, representing worsening of known TB despite appropriate therapy
- Unmasking IRIS: Occurs when ART unmasks previously subclinical or incubating TB infection
- Peak risk period: Within 2 weeks of ART initiation during TB treatment 1
- Patients starting ART within 2 weeks have higher IRIS rates compared to those starting between 8-12 weeks 1
High-Risk Patient Profile
- CD4+ lymphocyte count <50 cells/μL is the strongest predictor 1
- Earlier ART initiation timing (within 2 weeks of TB treatment start)
- HIV-coinfected patients have relative risk of 1.88 (95% CI, 1.31–2.69) for developing IRIS when receiving ART during TB therapy 1
Clinical Manifestations
IRIS presents with paradoxical worsening including:
- High fevers and worsening respiratory symptoms
- Enlarging or new lymphadenopathy with increased inflammation
- Expanding CNS lesions
- Worsening pulmonary infiltrates
- New or increasing pleural effusions
- Intra-abdominal or retroperitoneal abscesses 1
Critical Timing Considerations by TB Site
CNS Tuberculosis (Including TB Meningitis)
Delay ART for 8 weeks after starting TB treatment, even in patients with CD4 <50 cells/μL, as early ART initiation (within 2 weeks) is associated with increased adverse events and higher mortality due to severe neurological IRIS complications 1.
Non-CNS Tuberculosis
Earlier ART initiation (within 2-8 weeks) is generally recommended despite IRIS risk, as benefits of immune reconstitution outweigh risks in most cases.
Important Clinical Context
Common pitfall: The evidence provided discusses TB IRIS (immune reconstitution syndrome in HIV/TB coinfection), which is distinct from tuberculous iris granuloma or tubercular iridocyclitis (ocular TB manifestations).
For ocular TB specifically: Iris granulomas and tuberculous iridocyclitis can occur as direct manifestations of TB infection, typically presenting as unilateral granulomatous anterior uveitis, chronic iridocyclitis, or well-circumscribed iris lesions 2, 3, 4. These are not IRIS phenomena but rather direct TB involvement of ocular structures.